Sanofi (SNY) Total Current Liabilities (2009 - 2026)

Sanofi has disclosed Total Current Liabilities across 18 years of filings, most recently posting $37.1 billion for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 12.83% year-over-year to $37.1 billion; the TTM figure through Jun 2026 stood at $37.1 billion (up 12.83% YoY), while the FY2025 annual figure was $33.0 billion, up 126.0% from the prior year.
• Total Current Liabilities came in at $37.1 billion for Q2 2026 at Sanofi, up from $33.0 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $37.1 billion in Q2 2026 to a low of $16.1 million in Q4 2023.
• Average Total Current Liabilities over 5 years is $22.3 billion, with a median of $27.0 billion recorded in 2023.
• Year-over-year, Total Current Liabilities slumped 99.64% in 2022 and soared 89212.82% in 2024.
• Over 5 years, Total Current Liabilities stood at $86.7 million in 2022, then plunged by 81.39% to $16.1 million in 2023, then soared by 89212.82% to $14.4 billion in 2024, then surged by 128.9% to $33.0 billion in 2025, then gained by 12.48% to $37.1 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $37.1 billion in Q2 2026, $33.0 billion in Q4 2025, and $32.9 billion in Q2 2025.